Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.
Adding another reason for doctors to avoid the overuse of antibiotics, new research shows that a reduction in the variety of microbes in the gut interferes with the immune system's ability to fight off disease.
Marine sponges and the deep-sea ecosystem are comparatively under-studied and under-exploited compared with life in shallower waters - but a team of scientists from the University of Plymouth are identifying and developing potential new antimicrobials produced by the microbiome of sponges which live deep beneath the ocean surface.
Nanotechnology has made another breakthrough at the University of California San Diego. For the first time the researchers have shown that micromotors or microscopic robots could be used to treat a bacterial infection in the stomach in mice models win the laboratory.
It is important to keep in mind that nontuberculous mycobacteria are environmental, and so unlike mycobacterial tuberculosis, generally this is not a person to person transmitted disease. The organisms are found universally in water and soil and so most people are exposed on a daily basis.
As antibiotic resistance rises and fears over superbugs grow, scientists are looking for new treatment options.
The Centers for Disease Control and Prevention (CDC) has released a Health Alert Network (HAN) Health Advisory on 7th August 2017, Monday, in order to alert the health care facilities and the public health department on the increase in the reported cases of cyclosporiasis.
A short exposure to an alternating magnetic field might someday replace multiple surgeries and weeks of IV antibiotics as treatment for stubborn infections on artificial joints, new research suggests.
Collaborators in a new nationwide program for hospitals designed to improve the recovery of surgical patients have identified their first set of evidence-based recommendations: a care plan for colon and rectal surgical procedures.
Researchers at Uppsala University have developed a new method for very rapidly determining whether infection-causing bacteria are resistant or susceptible to antibiotics.
Amid all the turbulence over the future of the Affordable Care Act, one facet continues unchanged: President Donald Trump's administration is penalizing more than half the nation's hospitals for having too many patients return within a month.
A research team based at the University of Chicago has overcome challenges that have limited gene therapy and demonstrated how their novel approach with skin transplantation could enable a wide range of gene-based therapies to treat many human diseases.
Organisms causing urinary tract infections (UTI) are increasingly proving to be ineffective or showing resistance to drugs that are used to kill the germs. This phenomenon has been increasing worldwide, especially to commonly used antimicrobials (drugs) in children.
Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.
On July 24 Vanderbilt scientist Eric Skaar, Ph.D., MPH, summarized his group's latest paper in a tweet: "If S. aureus is going to drink our blood like a vampire, let's kill it with sunlight."
Two new discoveries from Edward Yu's Iowa State University laboratory are adding to the scientific understanding of how bacteria resist antibiotics.
Antibiotics are lifesaving drugs, but overuse is leading to one of the world's most pressing health threats: antibiotic resistance.
Antibiotic resistance of the bacterium Staphylococcus aureus is responsible for 11,300 deaths a year in the United States alone -- a figure that corresponds to half of all deaths caused by gram-positive resistant bacteria in that country.
Antibiotics are a boon to mankind and as more and more microorganisms are developing a resistance to these drugs, researchers are delving deeper into the mechanisms of this resistance. It is a commonly held view that once begun, a course of antibiotics should be completed to prevent the emergence of resistance among the microbes.
Sinus infections are one of the most common reasons patients walk out of the doctor's office with an antibiotic prescription in hand. The problem is that bacteria causes only about one-third of sinus infections, which means most patients are inappropriately receiving antibiotics.
A team of scientists are to pool their expertise to tackle one of the biggest health challenges facing society - the ability of common infections to resist drug treatment.